Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Lab-grown skin layer could replace animal testing
Scientists have developed the first ever lab grown epidermis.
Skin model could help develop treatments for skin conditions

Scientists have developed the first ever lab-grown skin layer. It could replace animal testing for drugs and cosmetics, as well as helping to develop new treatments for skin disorders.

The skin layer has been grown from human stem cells. It is the first lab-grown epidermis with the functional permeability barrier needed for drug testing.

Leading the research team from Kings College London, Dr Dusko Ilic said their new method could be scaled up for commercial testing of drugs and cosmetics.

Scientists used human stem cells to create an unlimited supply of pure keratinocytes - the main cell type in the epidermis.

These were used to produce 3D epidermal equivalents in a high-to-low humidity environment to build the functional barrier for protecting the body from losing moisture and preventing entry of chemicals, toxins and microbes.

The study, which has been published in the journal Stem Cell Reports, was carried out in collaboration with the San Francisco Veteran Affairs Medical Center (SFVAMC).

Scientists say the model can be used to study conditions such as ichthyosis (dry, flaky skin) and atopic dermatitis, where the skin's barrier is defective.

Dr Theodora Mauro, leader of the SFVAMC team says: "We can use the model to study how the skin barrier develops normally, how the barrier is impaired in different diseases and how we can stimulate its repair and recovery."

Furthermore, Dr Ilic says the model could be tailored to study particular skin conditions and sensitivities in different populations, by growing epidermal equivalents representing different types of skin.

Become a member or log in to add this story to your CPD history

FIVP announces third series of Practice Matters

News Story 1
 The Federation of Independent Veterinary practices (FIVP) has announced a third season of its podcast, Practice Matters.

Hosted by Ian Wolstenholme, series three will focus on the Competition and Markets Authority (CMA) investigation, including a discussion about some of the expected impacts on independent veterinary colleagues.

Episode one launches on 13th January with guests Drs David Reader and Scott Summers, who will draw on their research into the CMA investigation and provide insights into themes such as transparency, pricing and consumer trust.

Ian Wolstenholme said: "In its third series, we will try and hone in on what the changes will mean in reality for independent practices with advice and guidance on implementation and delivery, drawing on the experience of our own team and other experts in the profession. Hope you can join us soon!" 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk